GH Research (GHRS)
21.43
-1.82 (7.83%)
Upcoming Events
Latest Headlines
Form 6-K GH Research PLC For: Jun 04
June 4, 2026 8:36 AM - SEC Filing
GH Research publishes Phase 2a postpartum depression trial results
June 4, 2026 7:01 AM - StreetInsider
GH Research Announces Publication of Phase 2a Postpartum Depression Results
June 4, 2026 7:00 AM - Globe NewsWire
Form 6-K GH Research PLC For: May 21
May 21, 2026 7:01 AM - SEC Filing
Form EFFECT GH Research PLC
May 20, 2026 6:04 AM - SEC Filing
GH Research PLC (GHRS) PT Lowered to $65 at H.C. Wainwright
May 19, 2026 6:50 AM - StreetInsider
Form SCHEDULE 13G/A GH Research PLC Filed by: Lynx1 Capital Management LP
May 18, 2026 9:31 PM - SEC Filing
Form SCHEDULE 13G/A GH Research PLC Filed by: Lynx1 Capital Management LP
May 15, 2026 4:39 PM - SEC Filing
GH Research PLC (GHRS) PT Raised to $35 at Cantor Fitzgerald on Model Update
May 15, 2026 7:28 AM - StreetInsider
Canaccord Reiterates Buy Rating on GH Research PLC (GHRS)
May 15, 2026 6:36 AM - StreetInsider
GH Research PLC (GHRS) PT Lowered to $39 at Citizens on Recent Equity Financing
May 15, 2026 5:00 AM - StreetInsider
Form 6-K GH Research PLC For: May 14
May 14, 2026 4:30 PM - SEC Filing
GH Research (GHRS) files $400M mixed shelf
May 14, 2026 9:22 AM - StreetInsider
Form F-3 GH Research PLC
May 14, 2026 9:21 AM - SEC Filing
GH Research enters $200 million at-the-market equity offering agreement
May 14, 2026 9:12 AM - StreetInsider
Form 424B5 GH Research PLC
May 14, 2026 9:02 AM - SEC Filing
Form 6-K GH Research PLC For: Mar 31
May 14, 2026 7:22 AM - SEC Filing
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026 7:00 AM - Globe NewsWire
Form 6-K GH Research PLC For: May 13
May 13, 2026 4:46 PM - SEC Filing
Form 6-K GH Research PLC For: May 13
May 13, 2026 7:01 AM - SEC Filing
Form 6-K GH Research PLC For: Apr 30
April 30, 2026 4:20 PM - SEC Filing
Form 424B5 GH Research PLC
April 29, 2026 8:27 AM - SEC Filing
GH Research prices $117.5 million share offering at $18 per share
April 29, 2026 8:02 AM - StreetInsider
GH Research Announces Pricing of $117.5 Million Underwritten Offering
April 29, 2026 8:00 AM - Globe NewsWire
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
April 20, 2026 9:00 AM - Globe NewsWire
Psychedelic drug developers rally after Trump orders FDA to expedite reviews
April 20, 2026 6:43 AM - StreetInsider
Psychedelic stocks soar after Trump signs executive order to fast-track treatments
April 20, 2026 6:08 AM - StreetInsider
Form 3 GH Research PLC For: Mar 18 Filed by: Moore Duncan
April 17, 2026 6:19 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Cameron Aaron Luke
April 2, 2026 5:52 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Hanley Dermot John
April 2, 2026 5:43 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Halle Magnus Clemensen
April 2, 2026 5:36 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Forer Michael
April 2, 2026 5:35 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Valcheva Velichka
April 2, 2026 5:35 PM - SEC Filing
Form 3 GH Research PLC For: Mar 18 Filed by: Ryan Julie
April 2, 2026 5:33 PM - SEC Filing
Form 3 GH Research PLC For: Apr 01 Filed by: Schonharting Florian
April 1, 2026 4:02 PM - SEC Filing
Form 6-K GH Research PLC For: Mar 25
March 25, 2026 11:15 AM - SEC Filing
GH Research publishes phase 2b depression drug results in JAMA
March 25, 2026 11:10 AM - StreetInsider
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
March 25, 2026 11:10 AM - Globe NewsWire
Form 6-K GH Research PLC For: Mar 16
March 16, 2026 7:38 AM - SEC Filing
GH Research PLC (GHRS) PT Raised to $34 at Guggenheim
March 10, 2026 6:40 AM - StreetInsider
Full Article List
